Top compounds associated with response to LRIT3


Feature Type Standardized
Nominal ANOVA
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA WZ8040 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA SU11274 CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA TL-2-105 GDSC1000 pan-cancer AAC 0.12 0.0003
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.11 0.0003
mRNA tivozanib GDSC1000 pan-cancer AAC 0.13 0.0003
mRNA pac-1 CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA Nilotinib CTRPv2 pan-cancer AAC 0.14 0.0004
Download CSV